Literature DB >> 11489285

Autosomal dominant Kufs' disease: a cause of early onset dementia.

S A Josephson1, R E Schmidt, P Millsap, D Q McManus, J C Morris.   

Abstract

Kufs' disease is the rare, adult-onset form of the neuronal ceroid-lipofuscinoses (NCL). Two clinical Kufs' phenotypes have been described, one featuring generalized tonic-clonic seizures and the other characterized by dementia. Autosomal dominant inheritance of Kufs' disease has been reported for only two families. The genetic and molecular defects underlying Kufs' disease are unknown. We report a third family with apparent autosomal dominant Kufs' disease in a family of English ancestry. Ten individuals (five men, five women) have been affected over five generations. Age of onset typically is in the fourth decade of life and is heralded by seizures. Clinical and neuropsychological assessments in several affected individuals, however, confirm the presence of dementia and follow-up evaluations suggest that dementia is the primary disabling feature of the illness. Motor abnormalities also are frequent. Neuropathological examination (three cases) documents the presence of neuronal lipopigment accumulation consistent with NCL. The combination of dementia and seizures in this and two other reported families with autosomal dominant Kufs' disease suggest that this entity represents a distinctive clinicopathological entity. Dementia is prominent but is almost always associated with generalized seizures and motoric disturbances early in the disease course. Kufs' disease should be considered in the differential diagnosis of early onset, atypical dementia.

Entities:  

Mesh:

Year:  2001        PMID: 11489285     DOI: 10.1016/s0022-510x(01)00546-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis.

Authors:  Marie Abitbol; Jean-Laurent Thibaud; Natasha J Olby; Christophe Hitte; Jean-Philippe Puech; Marie Maurer; Fanny Pilot-Storck; Benoit Hédan; Stéphane Dréano; Sandra Brahimi; Delphine Delattre; Catherine André; Françoise Gray; Françoise Delisle; Catherine Caillaud; Florence Bernex; Jean-Jacques Panthier; Geneviève Aubin-Houzelstein; Stéphane Blot; Laurent Tiret
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 3.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

4.  Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.

Authors:  Lenka Nosková; Viktor Stránecký; Hana Hartmannová; Anna Přistoupilová; Veronika Barešová; Robert Ivánek; Helena Hůlková; Helena Jahnová; Julie van der Zee; John F Staropoli; Katherine B Sims; Jaana Tyynelä; Christine Van Broeckhoven; Peter C G Nijssen; Sara E Mole; Milan Elleder; Stanislav Kmoch
Journal:  Am J Hum Genet       Date:  2011-08-04       Impact factor: 11.025

Review 5.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

Review 6.  Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis.

Authors:  Nima Naseri; Manu Sharma; Milen Velinov
Journal:  Clin Genet       Date:  2020-08-26       Impact factor: 4.438

7.  Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis.

Authors:  Bruno A Benitez; David Alvarado; Yefei Cai; Kevin Mayo; Sumitra Chakraverty; Joanne Norton; John C Morris; Mark S Sands; Alison Goate; Carlos Cruchaga
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

8.  Primary fibroblasts from CSPα mutation carriers recapitulate hallmarks of the adult onset neuronal ceroid lipofuscinosis.

Authors:  Bruno A Benitez; Mark S Sands
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

9.  Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss.

Authors:  Bruno A Benitez; Nigel J Cairns; Robert E Schmidt; John C Morris; Joanne B Norton; Carlos Cruchaga; Mark S Sands
Journal:  Acta Neuropathol Commun       Date:  2015-11-26       Impact factor: 7.801

10.  LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.

Authors:  Philipp Trepte; Sabrina Kruse; Simona Kostova; Sheila Hoffmann; Alexander Buntru; Anne Tempelmeier; Christopher Secker; Lisa Diez; Aline Schulz; Konrad Klockmeier; Martina Zenkner; Sabrina Golusik; Kirstin Rau; Sigrid Schnoegl; Craig C Garner; Erich E Wanker
Journal:  Mol Syst Biol       Date:  2018-07-11       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.